Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

STEPHEN J FREEDLAND

Allopathic & Osteopathic Physicians Urology

NPI
1760572937
CMS profile
897355
Location
WEST HOLLYWOOD, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$186,683.91

80 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

Other CMS categories — not shown on this page

Research Payments

CMS also publishes Research Payments as a separate dataset. This site does not currently mirror it, and no research figure is shown on this page. This provider appears in that dataset.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

These records are published by CMS and can be viewed on this provider’s official CMS record. View this provider on CMS Open Payments ↗

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

By paying entity

PY2021 · entire year · sorted by reported total

Paying entityAmountRecords
GENZYME CORPORATION $70,848.48 30
PFIZER INC. $57,530.00 10
AstraZeneca Pharmaceuticals LP $24,229.18 30
Merck Sharp & Dohme Corporation $16,860.00 4
Bayer HealthCare Pharmaceuticals Inc. $10,350.00 2
Janssen Global Services, LLC $2,790.00 1
Astellas Pharma Global Development $2,317.50 1
AstraZeneca UK Limited $1,745.25 1
Ambu Inc. $13.50 1

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

80 matching records · $186,683.91 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 80 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–50 of 80.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
PFIZER INC. $13,875.0012/27/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026833187513 CMS
PFIZER INC. $4,000.0012/27/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026833385603 CMS
PFIZER INC. $2,125.0012/27/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026833385605 CMS
Merck Sharp & Dohme Corporation $4,360.0012/15/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026848597189 CMS
Bayer HealthCare Pharmaceuticals Inc. $1,150.0012/09/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026789083959 CMS
GENZYME CORPORATION $27.1012/08/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261061088387 CMS
GENZYME CORPORATION $20.0012/08/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261061088389 CMS
GENZYME CORPORATION $113.0112/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026843516667 CMS
GENZYME CORPORATION $3,486.0012/08/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026843516675 CMS
AstraZeneca Pharmaceuticals LP $2,700.0011/17/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026830053393 CMS
GENZYME CORPORATION $5,621.0011/17/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026843516403 CMS
AstraZeneca UK Limited $1,745.2511/09/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026829640855 CMS
AstraZeneca Pharmaceuticals LP $1,050.0010/25/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026829881719 CMS
AstraZeneca Pharmaceuticals LP $369.9910/22/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026829612469 CMS
GENZYME CORPORATION $99.9210/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261061088391 CMS
GENZYME CORPORATION $9.1810/21/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261061088393 CMS
GENZYME CORPORATION $118.0010/21/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261061088395 CMS
GENZYME CORPORATION $6,972.0010/21/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026843516691 CMS
GENZYME CORPORATION $370.0210/21/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026843516695 CMS
GENZYME CORPORATION $6,972.0010/20/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026843516411 CMS
GENZYME CORPORATION $356.0710/20/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026843516415 CMS
GENZYME CORPORATION $85.4910/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026843516699 CMS
GENZYME CORPORATION $1,047.2510/20/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026843516703 CMS
GENZYME CORPORATION $370.0310/20/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026843516707 CMS
Merck Sharp & Dohme Corporation $4,250.0010/20/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026848526851 CMS
Merck Sharp & Dohme Corporation $5,250.0010/13/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026848597181 CMS
GENZYME CORPORATION $6,972.0009/27/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026843516345 CMS
GENZYME CORPORATION $276.9709/27/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026843516349 CMS
GENZYME CORPORATION $123.1809/27/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026843516631 CMS
GENZYME CORPORATION $4.2509/27/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026843516637 CMS
GENZYME CORPORATION $280.5009/27/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026843516641 CMS
GENZYME CORPORATION $57.7509/27/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026843516645 CMS
GENZYME CORPORATION $11.7609/27/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026843516649 CMS
GENZYME CORPORATION $5,219.5009/22/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026843516383 CMS
AstraZeneca Pharmaceuticals LP $1,050.0009/14/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026829551935 CMS
GENZYME CORPORATION $2,324.0009/09/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026843516395 CMS
AstraZeneca Pharmaceuticals LP $1,050.0009/05/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026829741913 CMS
AstraZeneca Pharmaceuticals LP $805.5008/30/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026830093519 CMS
PFIZER INC. $500.0008/30/2021 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026833385607 CMS
Ambu Inc. $13.5008/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026833649105 CMS
AstraZeneca Pharmaceuticals LP $1,050.0008/24/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026829432969 CMS
AstraZeneca Pharmaceuticals LP $150.0008/19/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026829511435 CMS
AstraZeneca Pharmaceuticals LP $300.0008/18/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026829963755 CMS
GENZYME CORPORATION $2,324.0008/18/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026843516299 CMS
AstraZeneca Pharmaceuticals LP $2,150.0008/05/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026829845183 CMS
AstraZeneca Pharmaceuticals LP $4,300.0008/03/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026830063807 CMS
Merck Sharp & Dohme Corporation $3,000.0007/28/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026848435675 CMS
GENZYME CORPORATION $5,261.0007/21/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026843516407 CMS
AstraZeneca Pharmaceuticals LP $2,150.0007/20/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026830002015 CMS
Astellas Pharma Global Development $2,317.5007/14/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026831024747 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $146,255.45 96
PY2020 $155,524.61 49
PY2021 $186,683.91 80
PY2022 $295,578.31 106
PY2023 $251,171.71 68
PY2024 $470,855.29 167
PY2025 $431,204.22 122

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Cite this record.

Plain
STEPHEN J FREEDLAND, NPI 1760572937. IndustryPayments, data edition 2026-07-26T04:22:22Z. https://industrypayments.org/provider/npi-1760572937.
APA 7
IndustryPayments. (2026). STEPHEN J FREEDLAND, NPI 1760572937 (Data edition 2026-07-26T04:22:22Z) [Data set]. https://industrypayments.org/provider/npi-1760572937
Bluebook
STEPHEN J FREEDLAND, NPI 1760572937, IndustryPayments (data edition 2026-07-26T04:22:22Z), https://industrypayments.org/provider/npi-1760572937.

Source: Centers for Medicare & Medicaid Services, Open Payments.